Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages 2790-2797

  Aogi, Kenjiro ^a   Kitahara, Kenji ^a   Urquidi, Virginia ^b   Tarin, David ^b,c   Goodison, Steve ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; TELOMERASE; TUMOR MARKER;

ARTICLE; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; EXON; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; THYROID TUMOR; TUMOR DIAGNOSIS;

ANTIGENS, CD44; DNA-BINDING PROTEINS; HUMANS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TELOMERASE; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032719044     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Watson, J. D. Origin of concatemeric T4 DNA. Nat. New Biol., 239: 197-201, 1997.
2. Olovnikov, A. M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol., 41: 181-190, 1973.
3. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
4. Shay, J. W., and Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer, 33: 787-791, 1997.
5. Urquidi, V., Tarin, D., and Goodison, S. Telomerase in cancer: clinical applications. Ann. Med., 30: 419-430, 1998.
6. Sugino, T., Yoshida, K., Bolodeoku, J., Tarin, D., and Goodison, S. Telomerase activity and its inhibition in benign and malignant breast lesions. J. Pathol., 183: 57-61, 1997.
7. Yoshida, K., Sugino, T., Tahara, H., Woodman, A., Bolodeoku, J., Nargund, V., Fellows, G., Goodison, S., Tahara, E., and Tarin, D. Telomerase activity in bladder carcinomas and its implications for non-invasive diagnosis by detection of exfoliated cancer cells in urine. Cancer (Phila.), 79: 362-369, 1997.
8. Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., and Coffey, D. S. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res., 56: 218-222, 1996.
9. Chadeneau, C., Hay K., Hirte, H. W., Gallinger, S., and Bacchetti, S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res., 55: 2533-2536, 1995.
10. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
11. Wright, W. E., Shay, J. W., and Piatyszek, M. A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res., 23: 3794-3795, 1995.
12. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., and Yu, J. The RNA component of human telomerase. Science (Washington DC), 269; 1236-1241, 1995.
13. Ito, H., Kyo, S., Kanaya, T., Takakura, M., Koshida, K., Namiki, M., and Inoue, M. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clin. Cancer Res., 4: 2807-2810, 1998.
14. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science (Washington DC), 277: 955-959, 1997.
15. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., and Bell, J. I. Genomic structures of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternative spliced exons. Proc. Natl. Acad. Sci. USA, 89: 12160-12164, 1992.
16. Lesley, J., and Hyman, R. CD44 structure and function. Front. Biosci., 3: D616-D630, 1998.
17. Woodman, A. W., Sugiyama, M., Yoshida, K., Sugino, T., Borgya, A., Goodison, S., Matsumura, Y., and Tarin, D. Analysis of anomalous CD44 gene expression in human breast, bladder and colon cancer and correlation of observed mRNA and protein isoforms. Am. J. Pathol., 149: 1519-1530, 1996.
18. Friedrichs, K., Franke, F., Lisboa, B. W., Kugler, G., Gille, I., Terpe, H. J., Holzel, F., Maass, H., and Gunthert, U. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res., 55: 5424-5433, 1995.
19. Sugino, T., Gorham, H., Yoshida, K., Bolodeoku, J., Nargund, V., Cranston, D., Goodison, S., and Tarin, D. Progressive loss of CD44 gene expression in invasive bladder cancer. Am. J. Pathol., 149: 873-882, 1996.
20. Goodison, S., and Tarin, D. Clinical implications of anomalous CD44 gene expression in neoplasia. Front. Biosci., 3: 89-109, 1998.
21. Goodison, S., Yoshida, K., Sugino, T., Woodman, A. W., Gorham, H., Bolodeoku, J., Kaufmann, M., and Tarin, D. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors. Cancer Res., 57: 3140-3144, 1997.
22. Leber, B., and Bacchetti, S. Telomeres and telomerase in normal and malignant haematologic cells. Leuk. Lymphoma, 24: 1-9, 1996.
23. Kilian, A., Bowtell, D. D., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P. K., Duncan, E. L., Reddel, R. R., and Jefferson, R. A. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet., 6: 2011-2019, 1997.
24. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haufmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
25. Yoshida, K., Sugino, T., Tahara, H., Woodman, A., Bolodeoku, J., Nargund, V., Fellows, G., Goodison, S., Tahara, E., and Tarin, D. Telomerase activity in bladder carcinomas and its implications for non-invasive diagnosis by detection of exfoliated cancer cells in urine. Cancer (Phila.), 79: 362-369, 1997.
26. Yoshida, K., Sugino, T., Goodison, S., Warren, B., Nolan, D., Wadsworth, S., Mortensen, N. J., Toge, T., Tahara, E., and Tarin, D. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br. J. Cancer, 75: 548-553, 1997.
27. Califano, J., Ahrendt, S. A., Meininger, G., Westra, W. H., Koch, W. M., and Sidransky, D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res., 56: 5720-5722, 1996.
28. Cheng, A. J., Lin, J. D., Chang, T., and Wang, T. C. Telomerase activity in benign and malignant human thyroid tissues. Br. J. Cancer, 77: 2177-2180, 1998.
29. Haugen, B. R., Nawaz, S., Markham, N., Hashizumi, T., Shroyer, A. L., Werness, B., and Shroyer, K. R. Telomerase activity in benign and malignant thyroid tumors. Thyroid, 7: 337-342, 1997.
30. Aogi, K., Kitihara, K., Buley, I., Tahara, H., Sugino, T., Tarin, D., and Goodison, S. Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine needle aspirates. Clin. Cancer Res., 4: 1965-1970, 1998.
31. Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., Taylor, R. D., Carlos, R., Andrews, W. H., Wright, W. E., Shay, J. W., Harley, C. B., and Morin, G. B. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet., 17: 498-502, 1997.
32. Wen, J., Cong, Y. S., and Bacchetti, S. Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells. Hum. Mol. Genet., 7: 1137-1141, 1998.
33. Snijders, P. J., van Duin, M., Walboomers, J. M., Steenbergen, R. D., Risse, E. K., Helmerhorst, T. J., Verheijen, R. H., and Meijer, C. J. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res., 17: 3812-3818, 1998.
34. Park, T. W., Riethdorf, S., Riethdorf, L., Loning, T., and Janicke, F. Differential telomerase activity, expression of the telomerase catalytic subunit and telomerase-RNA in ovarian tumors. Int. J. Cancer, 4: 426-431, 1999.
35. Nakano, K., Watney, E., and McDougall, J. K. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am. J. Pathol., 3: 857-864, 1998.
36. Meeker, A. K., and Coffey, D. S. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochemistry, 62: 1323-1331, 1997.
37. Ramirez, R. D., Wright, W. E., Shay, J. W., and Taylor, R. S. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J. Investig. Dermatol., 108: 113-117, 1997.
38. Givehchian, M., Worner, S., Strater, J., Zoller, M., Heuschen, U., Heuschen, G., Lehnert, T., Herfarth, C., and von Knebel Doeberitz, M. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer. Eur. J. Cancer, 7: 1099-1104, 1998.
39. Woerner, S. M., Givehchian, M., Durst, M., Schneider, A., Costa, S., Melsheimer, P., Lacroix, J., Zoller, M., and Doeberitz, M. K. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium. Clin. Cancer Res., 10: 1125-1132, 1995.
40. Culp, L. A., and Kogerman, P. Plasticity of CD44s expression during progression and metastasis of fibrosarcoma in an animal model system. Front Biosci., 3: D672-D683, 1998.
41. Ermak, G., Gerasimov, G., Troshina, K., Jennings, T., Robinson, L., Ross, J. S., and Figge, J. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid. Cancer Res., 55: 4594-4598, 1995.
42. Gu, J., Daa, T., Kashima, K., Yokoyama, S., Nakayama, I., and Noguchi, S. Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells. Pathol. Int., 48: 184-190, 1998.
43. Ermak, G., Jennings, T., Robinson, L., Ross, J. S., and Figge J. Restricted patterns of CD44 variant expression in human papillary thyroid carcinoma. Cancer Res., 56: 1037-1042, 1996.
44. Goodison, S., Yoshida, K., Churchman, M., and Tarin, D. Multiple intron-retention occurs in tumor cell CD44 mRNA processing. Am. J. Pathol., 153: 1221-1228, 1998.